Mostly type I anaphylaxis occurs by conjugated cisplatin, mediated by IgE, and commonly occurs after several courses of chemotherapy, primarily manifesting as itching, urticaria, facial swelling, bronchospasm, and hypotension.[27] Additionally, skin-related adverse reactions owing to cisplatin have been occasionally reported. This evidence concerns the gene IGHE and urticaria.